4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-014546
Chief Financial Officer sold 7,071 shares at an average $100.21 ($708,576)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2026-02-10 | Sale 10b5-1 | −1,913 | $102.66 | $196,380 | 123,624 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-10 | Sale 10b5-1 | −700 | $103.68 | $72,574 | 122,924 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-10 | Sale 10b5-1 | −100 | $104.76 | $10,476 | 122,824 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-11 | Sale 10b5-1 | −2,266 | $98.37 | $222,906 | 120,558 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-11 | Sale 10b5-1 | −400 | $99.44 | $39,775 | 120,158 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-11 | Sale 10b5-1 | −100 | $100.85 | $10,085 | 120,058 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-12 | Sale 10b5-1 | −292 | $96.26 | $28,109 | 119,766 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-12 | Sale 10b5-1 | −400 | $97.67 | $39,069 | 119,366 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-12 | Sale 10b5-1 | −800 | $98.99 | $79,192 | 118,566 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-12 | Sale 10b5-1 | −100 | $100.10 | $10,010 | 118,466 | D |
| Derivatives | |||||||
| Smith Hunter C Chief Financial Officer | 2026-02-11 | Grant or award · Restricted Stock Units 10b5-1 | +25,000 | 25,000 | D | ||
| Smith Hunter C Chief Financial Officer | 2026-02-11 | Grant or award · Stock Options (Right to Buy) 10b5-1 | +37,500 | 37,500 | D | ||
| Open-market sales · 7,071 sh · avg $100.21 · $708,576 | |||||||
Loading xslF345X05/tm266263-1_4seq1.xml…